Zhejiang Palo Alto Pharmaceuticals,inc

China

 
Total IP 17
Total IP Rank # 88,093
IP Activity Score 1.9/5.0    12
IP Activity Rank # 73,071

Patents

Trademarks

8 0
0 0
9 0
0
 
Last Patent 2024 - Cyclic phosphate compound as dru...
First Patent 2017 - Hepatitis c virus inhibitor and ...

Latest Inventions, Goods, Services

2024 Invention Cyclic phosphate compound as drug for regulating cholesterol metabolism via liver delivery and us...
2023 Invention Oligonucleotide and use thereof against hepatitis b virus and hepatitis d virus. Provided are an...
2021 Invention Oligonucleotide and use thereof against hepatitis b virus and hepatitis d virus. 1231233 is GCG, ...
Invention Adenine-rich phosphorothioate oligonucleotide and anti-hepatitis virus application thereof. The p...
Invention Long-acting recombinant glp1-fc-cd47 protein and preparation and use thereof. The present invent...
2020 Invention Liver specific delivery-based entecavir prodrug, nucleoside cyclic phosphate compound, and applic...
Invention Cytarabine prodrug nucleoside cyclic phosphate compound based on liverspecific delivery and use. ...
Invention Liver specific delivery-based gemcitabine prodrug nucleoside cyclic phosphate compound, and appli...
2019 Invention Liver-specific delivery-based anti-hepatitis c prodrug nucleoside cyclo-phosphate compound and us...
Invention Long-acting recombinant glp1-fc-cd47 protein, preparation method and use thereof. Provided is a l...
2018 Invention Liver specific delivery-based antiviral prodrug nucleoside cyclophosphate compound and uses there...
Invention Cytarabine prodrug nucleoside cyclic phosphate compound based on liver-specific delivery and use....
Invention Hepatitis c virus inhibitor and uses thereof. Disclosed is a compound of formula (I-a) as an inhi...
Invention Liver-specific delivery-based anti-hepatitis c precursor drug nucleoside cyclophosphate compound ...
2017 Invention Hepatitis c virus inhibitor and application. Provided are a compound as shown in formula (I) usab...